Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,129 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
110年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (葡萄王) providing information about fund loans and endorsement guarantees, with all values reported as zero. The content is brief, factual, and relates to regulatory disclosure of financial guarantees and loans, without detailed financial statements or management commentary. It does not represent a full financial report, earnings release, or management discussion. Given the short length (602 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-06 Chinese
111年01月內部人持股轉讓(事前)
Director's Dealing Classification · 100% confidence The document contains tabular data about share transfers involving company directors and their spouses, including details on transfer methods, share quantities, and trust accounts. It is a report of personal share transactions by company insiders. There is no indication of financial results, meeting materials, or regulatory announcements beyond insider dealings. The presence of director names and share transfer details aligns with the definition of Director's Dealing filings.
2022-01-04 Chinese
110年12月內部人持股轉讓(事前)
Director's Dealing Classification · 100% confidence The document text is a tabular report detailing a share transfer involving a company director's spouse, including specifics on share quantities, transfer methods, and dates. The presence of terms like '董事配偶' (director's spouse), '贈與' (gift/transfer), and detailed shareholding changes indicates this is a report of personal share transactions by company insiders. There is no indication of financial results, meeting materials, or regulatory announcements beyond insider share dealings. Therefore, this document fits the definition of a Director's Dealing report.
2021-12-20 Chinese
110年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (葡萄王) reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements or analysis, no mention of a report being attached or published, and no regulatory certifications. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a Regulatory Filing (RNS) category, as it does not fit into any other specific report type and is a short, factual announcement.
2021-12-08 Chinese
110年11月營業收入
Regulatory Filings Classification · 95% confidence The document is a revenue summary report from a publicly listed company, providing monthly and cumulative net operating revenue figures with year-over-year comparisons. It includes notes on accounting standards (IFRS) and reporting practices but does not contain comprehensive financial statements or detailed analysis. The document length is short (774 characters), and it appears to be a regulatory disclosure of monthly revenue figures rather than a full financial report or earnings release. Given the nature of the content and the short length, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-12-08 Chinese
110年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report or announcement of a report but a direct disclosure of insider share transactions and holdings. Therefore, it fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider shareholdings, confirming the classification.
2021-12-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.